Amgen Inc.
Biotechnology / Biopharmaceuticals
Headquarters
Thousand Oaks, California
Company Size
Approximately 25,000 employees
Founded
1980
Visit Website Multinational Biopharmaceutical Company
About Amgen Inc.
Amgen is a global biotechnology company dedicated to transforming the lives of patients through innovative medicines developed by leveraging cutting-edge science and technology. It specializes in biologic medicines that treat serious illnesses, including products like Prolia, Enbrel, and Repatha among others.
Mission
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing, and delivering innovative human therapeutics.
Company Details
Industry
Biotechnology / Biopharmaceuticals
Revenue
Over $30 billion (2024 reported revenues)
Type
Multinational Biopharmaceutical Company
CEO
Robert A. Bradway